Abvc Biopharma (ABVC) Preferred Dividend Payments (2010 - 2012)
Abvc Biopharma's (ABVC) quarterly Preferred Dividend Payments came in at -$63333.0 in Q2 2012, up 81.0% on a YoY basis from -$34990.6 in Q3 2011, and down 151.02% quarter-over-quarter from -$25230.0 in Q1 2012.
Analysis
Abvc Biopharma (ABVC) Preferred Dividend Payments (2010 - 2012) Analysis & Trends
Abvc Biopharma (ABVC) has reported Preferred Dividend Payments for 3 consecutive years, with -$63333.0 the latest figure, recorded in Q2 2012.
- For the quarter ending Q2 2012, Preferred Dividend Payments rose 81.0% year-over-year to -$63333.0; the trailing twelve-month figure through Jun 2012 stood at $1.3 million (up 403.72% YoY), and the FY2011 full-year result was -$92497.0, up 50.41% from the prior year.
- Preferred Dividend Payments retreated to -$63333.0 in Q2 2012 per ABVC's latest filing, from -$25230.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $1.4 million in Q3 2011 and bottomed at -$333334.0 in Q2 2011.
- Historically, Preferred Dividend Payments has averaged $91623.8 across 3 years, with a median of -$30972.0 in 2010.
- The widest YoY moves for Preferred Dividend Payments: up 3211.57% in 2011, down 651.62% in 2011.
- Over 3 years, Preferred Dividend Payments stood at -$30972.0 in 2010, then climbed by 29.7% to -$21772.0 in 2011, then tumbled by 190.89% to -$63333.0 in 2012.
- According to Business Quant data, Preferred Dividend Payments over the past three periods registered -$63333.0, -$25230.0, and -$21772.0 for Q2 2012, Q1 2012, and Q4 2011 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Abvc Biopharma | 25.56 Mn | 25.56 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2012 | -63,333.00 |
| Mar 31, 2012 | -25,230.00 |
| Dec 31, 2011 | -21,772.00 |
| Sep 30, 2011 | 1.41 Mn |
| Jun 30, 2011 | -333,334.00 |
| Mar 31, 2011 | -17,052.00 |
| Dec 31, 2010 | -30,972.00 |
| Sep 30, 2010 | -45,181.00 |
| Jun 30, 2010 | -44,349.00 |